|
Ref: PXL/H.O./CIR-069/2014-15 Date: 19.12.2014
First time
BSM/Trade Delegation to
East European Countries
15-25th February 2015
To
All the Members of Council
Dear Sir/Madam,
We wish to inform the members that Council will be organizing BSM/Trade Delegation to Hungary, Czech Republic and Romania during 15-25th February 2015, as a part of export promotional activities under MDA scheme for 2014-15. The countries have been selected based on recommendations from our embassies / export potential available in those countries:
Export Opportunities in the proposed countries:
v Czech generic markets comprises of 34% of total market amounting to US$1.23 bn. Present share of India's generic exports to about 12.06 mn $ (2013-14), amounting to 1%. Good scope for furthering the share.
v In Romania, Generic drugs dominate the market by volumes to an extent of 75%. It amounts to value of 983 mn. It is expected to grow by CAGR of 7% up to 2018. FDIs are encouraged by Romanian Government. Acquiring local units will help in getting easy access to other European markets. Present India's exports are to the tune of US$ 27.50 mn with less than 3% in the generic market of Romania
v The generic market of Hungary in 2013 was worth US$ 863 mn, comprising of 34% of total market. Due to heavy price cuts imposed by Hungarian Govt., local companies are locking for business outside Hungary, leaving scope for Indian generics because of price advantage. Hungarian Govt. is also keen to come to an understanding on regularization of traditional medicines.
Other Important factors for consideration:
v These countries have the advantage of easier access to large EU market and easier access to other developed markets.
v Mutual recognition Law Facilitates easier access to other EU markets and other western markets including USA.
v Cost of operation in these countries is lower in comparison to most of the EU nations hence easier to export to other EU nations.
v Chinese companies are also looking to base their European operations in these countries take advantage of the mutual recognition law and thereby easy access for their products.
v Government of India also encourages strategic investments for enhancing India's exporters' market reach.
In view of the above, we advise members, particularly those who are aspiring to increase their market share in Europe & CIS markets, to take part in this important BSM/Trade delegation.
Tentative Travel plan:
|
Date
|
Travel
|
Proposed meetings (tentative)
|
|
15.2.2015
|
India - Budapest
|
Meetings with Ministry of Health/Human Resources, Ministry of Foreign Affairs and Trade National Institute of Pharmacy , Pharmaceutical Manufacturer's Association, Investment Promotion Agency, HIPA, Hungarian National Trade House, Debrecen University , Visit to Pharma City / Meetings with Pharma Companies
|
|
18.2.2015
|
Budapest-Bucharest
|
Meetings with local pharma companies, FDA officials, Pharma Associations
|
|
21.2.2015
|
Bucharest - Prague
|
B2B meeting with Pharmaceutical Importers, Distributors and Manufacturers, Meetings with State Institute for Drug Control, Meetings with local Pharma Associations
|
|
25.2.2015
|
Prague - India
|
Return
|
Other details like itinerary options, cost of travel & accommodation, visa requirements & charges, venues for meetings etc., will be informed in due course of time.
Assistance under MDA Scheme:
Members whose export turnover during previous financial year is less than Rs. 30.00 Crore are eligible for financial assistance of Rs.70,000/- towards cost of air fare, subject to other guidelines of MDA scheme. Members joining the delegation are required to participate in the Council arranged BSMs.
Interested members may confirm their participation by sending a mail to info@pharmexcil.comon or before 15.1.2015, along with a commitment/delegation fee of Rs. 30,000/- (Rupees thirty thousand only), which is refundable only in case of cancellation of event due to unavoidable circumstances. Interested Members may also fill in the attached delegation form & scanned copy of passport of participating delegate.
With regards,
Dr. P V Appaji
Director General
Encl:
Delegate Form
|
